Poor diet is one of the biggest drivers of chronic disease worldwide.

In this episode of The Health Curve, we explore one of the most basic but most confusing questions in health: what should people actually eat?

Host Dr. Jason Arora is joined by Dr. Jaime Schehr - integrative medicine physician, naturopathic doctor, registered dietitian, and Peloton's official Nutritionist @OnePeloton 🚴 - to cut through the noise on food, wellness, and the diets people are constantly told to follow.

Together, they break down the nutrition principles that matter most: why whole, recognizable foods matter, why most people need more fiber, how to think about protein, carbohydrates, fats, dairy, and micronutrients, and why so much of the confusion around food comes from misinformation, overprocessing, and convenience-driven eating.

The conversation also gets practical. What does a healthy plate actually look like? How should people think about smoothies, sugar, seed oils, hidden fats, and ultra-processed foods? And how can someone eat well even on a tight budget?

At its core, this episode is about simplifying nutrition. Not fad diets. Not food fear. Just the core principles that help most people eat better, feel better, and reduce their long-term risk of disease.

Follow The Health Curve @thehealthcurve for evidence-based conversations that make it easier to navigate health with clarity.

Chapters:
00:00 Intro
00:23 Dr. Jaime Schehr's background
03:13 Wellness trends and what's changed
07:53 Where nutrition fits in health today
11:22 Why nutrition feels so confusing
13:03 What a healthy diet actually looks like
17:01 What changed in the food pyramid
18:31 Do people eat enough protein?
21:43 How to eat healthy on a budget
24:52 Seed oils and ultra-processed foods
30:53 Why fiber matters so much
35:03 Carbohydrates explained
37:39 Smoothies, fruit, and sugar
42:21 Dairy explained
44:21 What micronutrients are
46:27 Where nutrition needs to go next
47:44 Closing thoughts

Skin cancer is the most common cancer in the world.

In this episode of The Health Curve, we explore how to actually reduce your risk - what matters, what doesn’t, and what most people get wrong.

Host Dr. Jason Arora is joined by Dr. Thomas Dobbs, NHS plastic surgeon and skin cancer specialist, to break down the basics: what skin cancer is, why it’s so common, and how it develops.

Together, we unpack the key risk factors (sun exposure, burns, tanning beds, skin type, age, and more), the main types of skin cancer, and what to look for on your own skin.

We also get practical about prevention. When should you use sunscreen? What does SPF actually mean? Do you need it on cloudy days? And how should you apply it properly?

Finally, we cut through the noise on some of the biggest myths online - does sunscreen actually cause cancer? Does it block vitamin D? Are certain ingredients unsafe? - and bring it back to what the evidence actually says.

If you care about your long-term health, this is one of the simplest areas where small habits can make a big difference.

Follow The Health Curve @thehealthcurve for evidence-based conversations that help you navigate your health with clarity.

What if aging itself becomes something we can measure, slow, and eventually treat?

In this episode of The Health Curve Podcast, host Dr. Jason Arora sits down with Dr. Eric Verdin, President and CEO of the Buck Institute for Research on Aging, to explore one of the biggest questions in science today: how close are we really to slowing human aging?

Dr. Verdin has spent decades at the forefront of aging biology, from early discoveries in epigenetics to leading one of the world’s premier longevity research institutes. In this conversation, he explains what fundamentally changed the field of aging research, why scientists are now more optimistic than ever, and what still stands in the way of translating these breakthroughs into real-world impact.

They discuss how aging shifted from being seen as a passive, inevitable process to something that can be actively influenced at the molecular level. They unpack the scientific bottlenecks that have slowed progress in humans, including long timelines, safety requirements, and the lack of a clear regulatory pathway for targeting aging itself.

The conversation also dives into emerging tools like epigenetic clocks and biomarkers of aging, which may allow us to measure biological age and track interventions in real time. They explore how AI and “digital twins” could accelerate research, and why funding, regulation, and existing healthcare incentives remain major constraints.

Beyond the science, this episode asks a deeper question: if we do succeed in extending human healthspan and lifespan, are we ready for the consequences? From inequality and access to environmental pressures and system design, Dr. Verdin shares a grounded, realistic perspective on what the future might look like.

They also discuss what actually matters today. From exercise, sleep, and social connection to the realities of supplements and longevity clinics, this episode separates what is actionable now from what remains experimental or overhyped.

If you’re trying to understand where longevity science really stands, and what it means for your life, your health, and society, this is a conversation you don’t want to miss.

Follow The Health Curve on YouTube for evidence-based conversations that cut through hype and help you navigate your health with clarity.

Chapters:

00:00 Intro
00:04 Welcome and Dr. Eric Verdin’s background
02:12 The discoveries that changed aging research
05:55 Why translating aging science to humans is so hard
07:31 AI, simulation, and digital twins in aging research
10:19 Aging as a scientific and cultural inflection point
12:26 How close are we to slowing aging in humans?
15:21 What we can do now vs future anti-aging drugs
15:44 Funding, regulation, and system barriers
19:58 Biomarkers, epigenetic clocks, and biological age
23:21 Subscribe and share
24:06 Dr. Verdin’s personal longevity habits
27:34 Supplements, hype, and regulation gaps
28:11 Zip code health and social determinants
32:30 Can drugs replace lifestyle?
35:57 The rise of longevity medicine
39:46 What’s real vs fluff in longevity today
41:05 Are we ready for longer lives?
44:13 AI, aging, and the future
44:50 Closing thoughts

🧠 Most people have heard of heart disease, diabetes, and obesity, but far fewer have been told about fatty liver, even though it now affects nearly 1 in 3 adults and sits at the center of all three.

In this episode of The Health Curve, Dr. Jason Arora is joined by Dr. Mazen Noureddin MD (Transplant Hepatologist, Professor of Medicine, and Founding Director of the Houston Liver Institute), one of the world’s leading experts in liver and metabolic disease, to unpack why fatty liver disease is not a niche diagnosis, but a defining feature of modern metabolic illness.

They explore what fatty liver actually is, why it often progresses silently for years, and how excess fat in the liver fuels inflammation, insulin resistance, cardiovascular disease, kidney disease, and shortened healthspan ⚠️. The conversation reframes fatty liver not as an isolated organ problem, but as a metabolic warning sign that the body’s systems are under strain.

Dr. Noureddin explains how fatty liver progresses from early fat accumulation to inflammation, scarring, and cirrhosis, often without obvious symptoms, and why so many people are still diagnosed too late. They also discuss who is most at risk (including people with type 2 diabetes, metabolic risk factors, and even those who are not overweight), how fatty liver is detected, and what simple tests can identify people who need urgent follow-up 🧪.

Importantly, this episode also brings hope. When caught early, fatty liver disease can be reversed. Dr. Arora and Dr. Noureddin walk through what actually works, from lifestyle interventions to newer FDA-approved therapies, while debunking common myths, internet misinformation, and false assumptions about alcohol, weight, and supplements 🌱💊.

Chapter Markers:

00:00 – Why fatty liver matters more than people realize
00:40 – What the liver actually does in metabolic health
01:45 – Why fatty liver sits at the center of cardiometabolic disease
02:10 – How excess fat builds up in the liver
03:30 – From fatty liver to inflammation, scarring, and cirrhosis
04:25 – What happens to the body as liver damage progresses
05:50 – Why fatty liver often has no early symptoms
06:15 – MAFLD, MASH, and the new terminology explained
07:35 – How fatty liver connects to diabetes, heart disease, and kidney disease
08:15 – Why these diseases “travel together”
09:15 – How people usually discover they have fatty liver
09:40 – Who should be screened — and why many cases are still missed
10:30 – Simple blood tests and the FIB-4 score explained
11:25 – Why early detection changes everything
11:35 – Can fatty liver be reversed?
12:05 – Lifestyle changes that actually work
13:10 – Diet patterns with the strongest evidence
14:00 – Medications for fatty liver: what’s now FDA-approved
15:40 – Common myths about fatty liver debunked
16:50 – Supplements, alcohol, and misinformation
17:15 – Key takeaways and closing reflections

🧠🍽️ Obesity and being overweight are often talked about like personal failures, but the science tells a very different story. In this episode of The Health Curve Podcast, Dr. Jason Arora and Dr. Marc-André Cornier (Past President of The Obesity Society, Professor of Medicine, and Director of the Division of Endocrinology at MUSC) explore obesity as a chronic, progressive disease shaped by biology 🧬 and an “obesogenic” environment.

Together, they unpack why obesity rates have risen so dramatically worldwide, how risk and complications vary across populations 🫀, and why low socioeconomic environments and “food deserts” can quietly stack the odds against health 🏙️. They also discuss why childhood obesity is so concerning 🧒📱, and what it means for long-term health systems, productivity, and society.

They also explore what evidence-based obesity care actually looks like today, walking through the full toolbox - from lifestyle foundations 🥗🏃 and medications (including GLP-1–based therapies) 💉 to bariatric surgery 🏥 , plus the hard truth that long-term disease often requires long-term treatment ⏳. They also tackle common fears and criticisms: side effects, cost and access 💸, direct-to-consumer “quick fixes” 🧪, and the tension between prevention and treatment.

If you’ve ever wondered why weight loss can feel like your body is fighting you - and what a smarter, more compassionate, science-based approach looks like - this episode is for you 💙.

Chapters"

00:00 – Introduction and guest background
01:10 – Why obesity is rising: genes × “obesogenic” environments
03:15 – Why obesity risk differs across populations and regions
04:20 – Visceral vs subcutaneous fat: metabolic vs mechanical health impacts
05:50 – The environmental drivers: food deserts, safety, inactivity, marketing
06:55 – Why childhood obesity is accelerating
08:20 – The societal and economic spillovers of obesity
10:50 – Why obesity meets the definition of a chronic disease
13:05 – Patient archetypes: cosmetic vs health vs “not on the radar”
14:30 – The obesity treatment toolbox: lifestyle, meds, surgery, teams
20:00 – Who should get what? BMI limits, waist measures, risk staging
23:35 – Expected weight-loss ranges: lifestyle vs GLP-1s vs surgery
26:10 – Long-term challenges: cost, coverage, adherence, access
29:15 – Side effects and safe prescribing: why supervision matters
31:35 – Direct-to-consumer risks, compounded meds, and regulation
33:45 – Prevention vs treatment: why it’s not either/or
36:30 – “Big food vs big pharma” concerns and stigma
39:50 – The future of obesity care: primary care, centers, virtual models
43:20 – What’s next in meds: multi-agonists, longer-acting options, muscle preservation

In this episode of The Health Curve Podcast, Dr. Jason Arora and Dr. Sanjai Sinha (MD at Mount Sinai Health System, New York City) explore what AI is actually doing in healthcare today, especially in primary care, where most people experience the system 🏥.

They unpack where AI is already outperforming humans in medicine, where it’s quietly reshaping daily clinical work through AI scribes and message automation, and where real concerns are emerging - including deskilling, over-reliance, and the growing use of AI by insurance companies to automate prior authorizations and denials 📄❌.

Rather than asking whether AI will replace doctors, this conversation asks a more urgent question: who is AI really being built for? Patients? Clinicians? Or systems optimized for speed, cost, and control?

This episode cuts through both AI hype and fear to offer a grounded, human-centered view of how AI could improve care, if it’s designed thoughtfully, and how it could just as easily make a broken system more efficient at doing the wrong things ⚖️.

Chapters

00:00 – Why AI is the right conversation to end the primary care series
00:30 – Where AI is already used in healthcare today
01:30 – AI vs humans in diagnostics: EKGs and heart disease
03:00 – Colonoscopy, cancer detection, and the risk of deskilling
05:30 – Why AI isn’t perfect — and why that matters
05:55 – How patients will encounter AI in primary care
06:00 – AI scribes, charting, and physician burnout
07:40 – Messaging, automation, and clinical decision support
08:55 – AI and insurance: faster decisions, more denials?
10:35 – Automating bad incentives in healthcare
11:40 – Where AI can meaningfully improve care quality
12:55 – Decision support, safety, and reducing redundant testing
14:30 – AI has been around longer than we think
15:50 – What AI means for patients navigating care
16:00 – Will AI replace primary care doctors?
17:20 – The real future: humans and AI working together
18:00 – Closing reflections

🧬 Longevity is everywhere right now, from wearables and supplements to expensive tests, clinics, and bold promises of optimization. But what actually helps most people live longer, healthier lives?

In this episode of The Health Curve Podcast, Dr. Jason Arora and Dr. Sanjay Sinha (MD at Mount Sinai Health System, New York City) explore longevity from a grounded, real‑world perspective, stepping back from the hype to ask what truly moves the needle for healthspan and lifespan at scale. Rather than focusing on elite diagnostics or experimental therapies, the conversation looks at why the fundamentals still matter most, and why - outside of healthy habits - traditional primary care remains the most powerful delivery system for longevity, for most people.

Together, they discuss how good primary care has always been about healthy aging 🏥⏳ - identifying risk early, preventing disease before it takes hold, and supporting sustainable behavior change over time. Along the way, they unpack the American Heart Association’s Life’s Essential 8 as a practical framework for longevity, and explain why small, realistic changes often outperform extreme or expensive interventions.

This episode reframes longevity as something accessible and scalable 🌍 , not a luxury pursuit for the few, but a set of evidence‑based principles that can benefit almost everyone, if we build the right systems around them 💙.

Chapters

00:00 – Introduction and guest background
00:55 – What is primary care and how has it changed?
02:45 – GP vs primary care physician: why the terminology is confusing
04:40 – Why primary care acts as the “quarterback” of healthcare
07:50 – How insurance and policy shaped today’s primary care system
08:40 – The shift toward transactional, on-demand healthcare
10:55 – Evidence that primary care improves health outcomes and equity
11:50 – The growing U.S. primary care shortage explained
13:50 – Why doctors are leaving primary care (pay, burnout, debt)
14:40 – What patients experience in today’s primary care system
16:45 – Telemedicine, retail clinics, and non-physician providers
18:00 – Concierge medicine and direct primary care models
21:20 – Why primary care is critical for longevity and healthspan
23:25 – Where primary care is headed next
26:10 – Why the U.S. underinvests in primary care compared to other countries
27:45 – Final reflections and closing

🏥 Primary care is the foundation of modern healthcare. Yet, in the United States, it’s quietly breaking down.

In this episode of The Health Curve Podcast, Dr. Jason Arora and Dr. Sanjay Sinha (MD at Mount Sinai Health System, New York City) explore what’s happening to primary care and why it matters for longevity, prevention, equity, and healthcare costs 🧠⏳.

Together, they explore how primary care has shifted from a relationship-based, longitudinal model 🤝 to a more fragmented and transactional system shaped by reimbursement pressures, burnout, consolidation, and technology 😮‍💨. They discuss the rise of telemedicine, retail clinics, concierge and direct primary care 💳, and what these changes mean for access, continuity, and long-term health.

The conversation also examines the growing primary care shortage 📉, why fewer physicians are entering the field, and the evidence 📊 showing that strong primary care systems are linked to longer life expectancy, better chronic disease control, fewer hospitalizations, and more equitable outcomes 🌍.

This episode is for anyone trying to understand why it’s become so hard to find a primary care doctor, and why primary care remains one of the most powerful, yet overlooked, tools we have for living longer, healthier lives 💙.

Chapters / Timestamps

00:00 – Introduction and guest background
00:55 – What is primary care and how has it changed?
02:45 – GP vs primary care physician: why the terminology is confusing
04:40 – Why primary care acts as the “quarterback” of healthcare
07:50 – How insurance and policy shaped today’s primary care system
08:40 – The shift toward transactional, on-demand healthcare
10:55 – Evidence that primary care improves health outcomes and equity
11:50 – The growing U.S. primary care shortage explained
13:50 – Why doctors are leaving primary care (pay, burnout, debt)
14:40 – What patients experience in today’s primary care system
16:45 – Telemedicine, retail clinics, and non-physician providers
18:00 – Concierge medicine and direct primary care models
21:20 – Why primary care is critical for longevity and healthspan
23:25 – Where primary care is headed next
26:10 – Why the U.S. underinvests in primary care compared to other countries
27:45 – Final reflections and closing